Millions of people across the world have sickle cell disease and live with challenging pain crises.

Know more. Do more. Together.

Novartis has partnered with Dr Alex Kumar, a global health physician and photographer, to tell the stories of people with sickle cell from the global community.

See more patient
stories here >>

Pain crises can be agonising, affecting your body, mind, and emotional health
— taking a toll on every part of your life.
Learn more about pain crisis >>

Site Map

This is a global website for TBD^® (ribociclib) and is intended for Healthcare Professionals outside the US.

TBD^® (ribociclib) is EMA approved

Healthcare Professionals
Patients

I am a Healthcare Professional outside the US
Enter site

The information on the site is not country-specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country. Please contact your local Novartis representative for local prescribing information via https://www.novartisoncology.com/our-company/contact-us.

IMPORTANT: The information on this website is based on the European Summary of Product Characteristics (EU SmPC)

US HCPs & Other
Country-Specific Websites

Below is a list of the countries that host a TBD website based on local label and in a local language. They are intended for healthcare professionals (HCPs) only. If you are a HCP from one of the countries listed below, click on your country’s link to be redirected to your country’s TBD website.

Choose Country

United States

I am a Patient Inside US
I am a Patient Outside US

You are now leaving NotAloneInSickleCell.com

You are about to leave the NotAloneInSickleCell.com website and enter a website operated by a third party. Novartis is not responsible for and does not control information contained on this third-party website.

Cancel